Clinical Trial Update: New Antipsychotic Strategies: Quetiapine and Risperidone vs. Fluphenazine in Treatment Resistant Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing quetiapine and risperidone against fluphenazine in treatment-resistant schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Fluphenazine (fluphenazine)
• Quetiapine (quetiapine)
• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED